The stock of Rockwell Medical Inc (RMTI) has gone up by 17.55% for the week, with a 15.71% rise in the past month and a 0.23% rise in the past quarter. The volatility ratio for the week is 9.73%, and the volatility levels for the past 30 days are 7.76% for RMTI. The simple moving average for the past 20 days is 22.22% for RMTI’s stock, with a -14.81% simple moving average for the past 200 days.

Is It Worth Investing in Rockwell Medical Inc (NASDAQ: RMTI) Right Now?

while the 36-month beta value is 1.48.Analysts have differing opinions on the stock, with 2 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”

Elon Musk just Triggered a BOOM in These Stocks

Something strange is happening in the stock market…. This select group of stocks are going absolutely bananas. And it's all because of Elon Musk. Get your copy of "Top 5 Tech Stocks to Buy in 2024"

Click Here to Download the FREE Report.


The average price point forecasted by analysts for Rockwell Medical Inc (RMTI) is $8.00, which is $5.79 above the current market price. The public float for RMTI is 24.95M, and currently, short sellers hold a 3.99% ratio of that floaft. The average trading volume of RMTI on November 16, 2023 was 324.23K shares.

RMTI) stock’s latest price update

The stock price of Rockwell Medical Inc (NASDAQ: RMTI) has jumped by 12.76 compared to previous close of 1.96. Despite this, the company has seen a gain of 17.55% in its stock price over the last five trading days. Seeking Alpha reported 2023-11-14 that Rockwell Medical, Inc. (NASDAQ:RMTI ) Q3 2023 Earnings Conference Call November 14, 2023 8:00 AM ET Company Participants Heather Hunter – SVP & Chief Corporate Affairs Officer Mark Strobeck – President & CEO Jesse Neri – SVP, Finance Conference Call Participants Anthony Vendetti – Maxim Group LLC Dipesh Patel – H.C. Wainwright Operator Good morning, and welcome to Rockwell Medical’s Third Quarter 2023 Results Conference Call and Webcast.

Analysts’ Opinion of RMTI

Many brokerage firms have already submitted their reports for RMTI stocks, with Piper Jaffray repeating the rating for RMTI by listing it as a “Overweight.” The predicted price for RMTI in the upcoming period, according to Piper Jaffray is $10 based on the research report published on June 24, 2019 of the previous year 2019.

RMTI Trading at 12.99% from the 50-Day Moving Average

After a stumble in the market that brought RMTI to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -64.58% of loss for the given period.

Volatility was left at 7.76%, however, over the last 30 days, the volatility rate increased by 9.73%, as shares surge +23.81% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +1.38% upper at present.

During the last 5 trading sessions, RMTI rose by +17.55%, which changed the moving average for the period of 200-days by +48.32% in comparison to the 20-day moving average, which settled at $1.8300. In addition, Rockwell Medical Inc saw 117.73% in overturn over a single year, with a tendency to cut further gains.

Stock Fundamentals for RMTI

Current profitability levels for the company are sitting at:

The net margin for Rockwell Medical Inc stands at -25.65. The total capital return value is set at -54.22, while invested capital returns managed to touch -77.93. Equity return is now at value -49.33, with -17.39 for asset returns.

Based on Rockwell Medical Inc (RMTI), the company’s capital structure generated 116.00 points at debt to equity in total, while total debt to capital is 53.70. Total debt to assets is 35.09, with long-term debt to equity ratio resting at 86.66. Finally, the long-term debt to capital ratio is 40.12.

When we switch over and look at the enterprise to sales, we see a ratio of 0.63, with the company’s debt to enterprise value settled at 3.35. The receivables turnover for the company is 11.96 and the total asset turnover is 1.53. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.00.


In a nutshell, Rockwell Medical Inc (RMTI) has experienced a better performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.